# LRRC70

## Overview
The LRRC70 gene encodes the leucine-rich repeat-containing 70 protein, which is part of a family of proteins characterized by the presence of leucine-rich repeat (LRR) motifs. These motifs are typically involved in protein-protein interactions, suggesting that LRRC70 may play a role in cellular communication or structural organization. Although the specific biological functions of the LRRC70 protein remain to be fully elucidated, it is hypothesized to be involved in processes such as cell adhesion or growth factor binding, which are critical for maintaining cellular integrity and signaling (Orentas2014Bioinformatic). The gene has garnered interest due to its potential implications in immune system function and its expression patterns in certain leukemias, indicating a possible role in disease mechanisms (Orentas2014Bioinformatic; Jebb2020Six). Further research is necessary to clarify the functional roles and clinical significance of LRRC70 in human health and disease.

## Clinical Significance
The clinical significance of the LRRC70 gene is still under investigation, but current research suggests potential implications in immune system function and leukemia. The loss of LRRC70 in bats has been linked to unique immune adaptations, indicating that alterations in this gene could affect immune responses in other species, including humans (Jebb2020Six). In the context of pediatric T-cell acute lymphoblastic leukemia (T-ALL) and pre-B acute lymphoblastic leukemia (pre-B-ALL), LRRC70 has been identified as a transcript shared between these leukemias, suggesting its expression is more common in these conditions than in normal tissues. This shared expression pattern implies a possible role in the pathology of these leukemias, although specific mutations or clinical conditions directly associated with LRRC70 have not been detailed (Orentas2014Bioinformatic).

While the gene is not well-described, it may play a role in cell adhesion or growth factor binding, which could be relevant to its involvement in disease mechanisms (Orentas2014Bioinformatic). Further research is needed to elucidate the precise clinical implications of LRRC70 mutations or expression alterations.


## References


[1. (Orentas2014Bioinformatic) Rimas J. Orentas, Jessica Nordlund, Jianbin He, Sivasish Sindiri, Crystal Mackall, Terry J. Fry, and Javed Khan. Bioinformatic description of immunotherapy targets for pediatric t-cell leukemia and the impact of normal gene sets used for comparison. Frontiers in Oncology, June 2014. URL: http://dx.doi.org/10.3389/fonc.2014.00134, doi:10.3389/fonc.2014.00134. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2014.00134)

[2. (Jebb2020Six) David Jebb, Zixia Huang, Martin Pippel, Graham M. Hughes, Ksenia Lavrichenko, Paolo Devanna, Sylke Winkler, Lars S. Jermiin, Emilia C. Skirmuntt, Aris Katzourakis, Lucy Burkitt-Gray, David A. Ray, Kevin A. M. Sullivan, Juliana G. Roscito, Bogdan M. Kirilenko, Liliana M. Dávalos, Angelique P. Corthals, Megan L. Power, Gareth Jones, Roger D. Ransome, Dina K. N. Dechmann, Andrea G. Locatelli, Sébastien J. Puechmaille, Olivier Fedrigo, Erich D. Jarvis, Michael Hiller, Sonja C. Vernes, Eugene W. Myers, and Emma C. Teeling. Six reference-quality genomes reveal evolution of bat adaptations. Nature, 583(7817):578–584, July 2020. URL: http://dx.doi.org/10.1038/s41586-020-2486-3, doi:10.1038/s41586-020-2486-3. This article has 234 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41586-020-2486-3)